Skip to main content

Home/ Dr. Goodyear/ Group items tagged octreotide

Rss Feed Group items tagged

Nathan Goodyear

Long-Acting Octreotide for the Treatment and Symptomatic Relief of Bowel Obstruction in... - 0 views

  •  
    Long term octreotide well tolerated in patients with recurrent ovarian cancer.  
Nathan Goodyear

The role of octreotide and somatostatin in acute a... [Digestion. 1999] - PubMed - NCBI - 0 views

  •  
    Octreotide useful in pancreatitis.
Nathan Goodyear

A phase II study of high-dose octreotide in patients with unresectable pancreatic carci... - 0 views

  •  
    Octreotide shown to be of some benefit in those with stage II to IV pancreatic cancer.  The number of individuals positively impacted was small (19%) for 12 weeks, but another tool in the battle against cancer.
Nathan Goodyear

Long‐acting octreotide versus placebo for treatment of advanced HCC: A random... - 0 views

  •  
    Octreotide, GH inhibitor, no better than placebo in liver cancer.
Nathan Goodyear

Octreotide - A Review of its Use in Treating Neuroendocrine Tumours - PMC - 0 views

  •  
    Octreotide prolongs time interval to tumor progression in neuroendocrine tumors.
Nathan Goodyear

Clinical Pharmacodynamic Effects of the Growth Hormone Receptor Antagonist Pegvisomant:... - 0 views

  •  
    Pegvisomant shown to provide more GH, IGF-1 suppression compared to octreotide. The doses used were 40, 60, and 80 mg SQ. The higher dose resulted in the greatest suppression.
Nathan Goodyear

Management of Bleeding in Patients with Advanced Cancer - 0 views

  •  
    therapies to try and control GI bleeding.
1 - 9 of 9
Showing 20 items per page